Browse Case Studies by
Case Studies in
- Corporate Governance
- Corporate Social Responsibility
- Economics
- Enterpreneurship
- Finance, Accounting & Control
- Leadership
- Marketing
- Organisational Behaviour / HRM
- Social Entrepreneurship
- Strategy
- All Case Studies »
Concept wise Case Studies
- Managing in Troubled Times
- Airline Industry
- Business Models - Vol. II
- Brand Management - Vol. II
- US Automobile Industry
- » All Concept wise Cases
Industry wise Case Studies
- Telecommunications Equipments and Services
- Retailing
- Media and entertainment
- Motion picture production and distribution
- Personal Computers
- » All Industry wise Cases
Region wise Case Studies
Managing in Troubled Times Case Study
Case Title:
Pfizer: Dearth of New Products and Future Challenges
Publication Year : 2005
Authors: Rajender Singh, Sumit Kumar Chaudhuri
Industry: Pharmaceuticals Manufacturers
Region: USA
Case Code: TRT0044
Teaching Note: Not Available
Structured Assignment: Not Available
OR
Abstract:
By the turn of the 21 st century, despite investing $7 billion a year on R&D, Pfizer has been witnessing constant decline in its productivity. Since 2001, Pfizer's shares have declined by 45% to $25 a share. Analysts estimate flat earnings for Pfizer in 2005 and 1.5% annual decline in its sales through 2010. Under such circumstances, Pfizer has initiated a comprehensive review of its business and the company is expected to undergo a major restructuring in 2005.
Pedagogical Objectives:
- To highlight the challenges faced by Pfizer
- To discuss the future strategies Pfizer would adopt to retain its market position.
Keywords : Pfizer; Pharmaceutical industry; Innovations; Blockbuster drugs; Acquisitions; Licensing; Regulatory measures; Research and development; Lipitor; Food and Drug Administration; Patent expiration; Managing in Troubled Times Case Study; Generic competitors; Ranbaxy Laboratories Limited; Restructuring; Decentralisation
